Hester Biosciences to repurpose BSL-3 facility as Covid vaccine demand tapers off
4 months ago•The Hindu Businessline
Hester Biosciences to develop inactivated influenza vaccine for poultry
9 months ago•The Hindu Businessline
HesterBio gains on acquiring technology for H9N2 avian influenza virus vaccine from ICAR - NIHSAD
9 months ago•Business Standard
Hold Hester Biosciences; target of Rs 2070: ICICI Direct
10 months ago•Moneycontrol
Hester Biosciences Ltd leads losers in ‘A’ group
1 year ago•Business Standard
Hester Biosciences boosted by strong demand for goat pox vaccine
1 year ago•Moneycontrol
Hester Bio spurts on ensuring adequate supply of Goat Pox Vaccine in India
1 year ago•Business Standard